Generics Products found!

Innovative

Biosimilars

Medical devices

Nutraceuticals

Filters

Nateglinide manufacturers

Filters

None products found

nateglinide

Tablets, film coated 60 mg, 120 mg, 180 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
PICS
Manufacturer #554
This company focuses on developing and manufacturing a range of pharmaceuticals and healthcare products. Their offerings include prescription medications, over-the-counter drugs, and potentially medical devices or supplements, though specifics are not provided. They appear to have a strong research and development focus, with expertise in several key therapy areas (not specified). The company operates within regions like the EU and North America, adhering to stringent GMP certifications for production. While patent information is unavailable, their commitment to innovation is evident through their product development pipeline.

Manufacturer usually replies in 8 days

nateglinide

Tablets 60 mg, 120 mg

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
FDA
Manufacturer #15910
This multinational pharmaceutical company focuses on a wide range of products, including prescription medications, over-the-counter drugs, APIs, and formulations. They have a strong presence in key global regions like North America, Europe, Japan, and Africa. Their expertise spans multiple therapeutic areas, particularly gastroenterology, cardiology, gynecology, diabetology, and oncology. They are known for their state-of-the-art manufacturing facilities that adhere to international standards such as USFDA, EU, MHRA UK, WHO Geneva, and TGA Australia. The company boasts a dedicated R&D team of over 350 scientists working on innovations in areas with unmet medical needs. They have achieved significant milestones by developing "world's first" innovations in lung cancer, tuberculosis, cardiovascular diseases, and gastroenterology. Their product portfolio includes a variety of dosage forms and they hold several patents for their innovative products.

Manufacturer usually replies in 57 days

nateglinide

Tablets 60 mg, 120 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #2303
A pharmaceutical manufacturer with over 25 years of experience that develops and produces fixed-dose and single-entity generic and specialty pharmaceutical products. The company offers an extensive range of injectable dosage forms, including parenterals, and also manufactures oral solids. Its facilities operate under recognised international quality certifications such as EU-GMP, ANVISA, PIC/S and TGA approvals, supporting reliable large-scale production of pharmaceutical products for global export while emphasizing efficacy, affordability and consistent quality.

Manufacturer usually replies in 19 days

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.